Hadi Danaee is a highly experienced professional in the field of Translational Medicine and Clinical Biomarkers. With a strong background in leading biomarker and companion diagnostic strategies, Hadi has held key positions at various renowned pharmaceutical companies such as HotSpot Therapeutics, Inc., Blueprint Medicines, TESARO/GSK, Takeda Pharmaceuticals International Co., and Millennium Pharmaceuticals. With a solid educational foundation from Harvard T.H. Chan School of Public Health and University of Connecticut, Hadi has demonstrated expertise in developing and implementing biomarker strategies for oncology programs, as well as leading research in molecular medicine.
Sign up to view 1 direct report
Get started